DeepMind Unveils AlphaFold: Next-Gen AI for Drug Discovery

A new AI model developed by Google DeepMind and Isomorphic Labs, capable of predicting the structure and interactions of proteins, DNA, RNA, ligands, and more.

Offers at least a 50% improvement in prediction accuracy for protein interactions with other molecules compared to existing methods.

Scientists can access most of AlphaFold 3's capabilities for free through the AlphaFold Server, an easy-to-use research tool.

Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges.

AlphaFold has been cited over 20,000 times and has been recognized for its scientific impact through awards like the Breakthrough Prize in Life Sciences.

Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp _____________ Disclaimer : Analytics Insight does not provide financial advice or guidance on cryptocurrencies and stocks. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. This article is provided for informational purposes and does not constitute investment advice. You are responsible for conducting your own research (DYOR) before making any investments. Read more about the financial risks involved here. Read More Stories